Knaus, P I <br/><br/>
A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.  [electronic resource] 

 -  Molecular and cellular biology  Jul 1996 
 - 3480-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0270-7306 
<br/><br/><label>Standard No.: </label>10.1128/MCB.16.7.3480  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Carcinoma, Hepatocellular<br/>Cell Division--drug effects<br/>Cell Line<br/>Chlorocebus aethiops<br/>Genes, Dominant<br/>Humans<br/>Liver Neoplasms<br/>Lymphoma, T-Cell, Cutaneous--genetics<br/>Molecular Sequence Data<br/>Point Mutation<br/>Protein Serine-Threonine Kinases<br/>Receptor, Transforming Growth Factor-beta Type II<br/>Receptors, Transforming Growth Factor beta--biosynthesis<br/>Recombinant Proteins--biosynthesis<br/>Sequence Homology, Amino Acid<br/>Signal Transduction<br/>Skin--pathology<br/>Skin Neoplasms--genetics<br/>Transfection<br/>Transforming Growth Factor beta--pharmacology<br/>Tumor Cells, Cultured